JNJ Jan 2025 120.000 call
- Zacks
Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Johnson & Johnson (JNJ) closed at $153.30, marking a +0.43% move from the previous day.
- Reuters
UPDATE 1-Caligan pushes ahead with board challenge at Anika, nominates two directors
Activist investor Caligan Partners has nominated two director candidates to Anika Therapeutics' seven member board, according to a regulatory filing on Monday, signaling plans to push ahead with a board challenge at the biotechnology company. The investment firm, which owns a roughly 4% stake and is one of Anika's 10 biggest shareholders, named former Johnson & Johnson executive Gary Fischetti and former healthcare technology executive and experienced board member James Hogan as its candidates, according to the filing.
- Reuters
Caligan pushes ahead with board challenge at Anika, nominates two directors
Activist investor Caligan Partners has nominated two director candidates to Anika Therapeutics' seven member board, according to a regulatory filing on Monday, signaling plans to push ahead with a board challenge at the biotechnology company. The investment firm, which owns a roughly 4% stake and is one of Anika's 10 biggest shareholders, named former Johnson & Johnson executive Gary Fischetti and former healthcare technology executive and experienced board member James Hogan as its candidates, according to the filing.
